The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Much Larger Will The Cardiac Marker Testing Market Become By 2030 Compared To 2026?
The cardiac marker testing market size has experienced swift expansion recently. This market is projected to expand from $7.19 billion in 2025 to $7.93 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.3%. Historically, this growth was influenced by factors such as the restricted access to high-sensitivity cardiac marker tests, a dependency on centralized laboratory testing, the increasing occurrence of cardiovascular diseases, heightened consciousness among healthcare professionals, and traditional manual diagnostic methods.
The cardiac marker testing market is projected to experience substantial expansion in the coming years, reaching a size of $11.61 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.0%. This projected increase during the forecast period is primarily driven by factors such as the creation of automated and portable devices for cardiac marker testing, the increasing uptake of point-of-care diagnostic solutions, the incorporation of these tests into digital health platforms, the expanding elderly population accompanied by heightened cardiovascular risks, and ongoing enhancements in the sensitivity of reagents and test kits. Key trends anticipated during this period encompass the growing preference for high-sensitivity cardiac biomarker assessments, the proliferation of point-of-care testing sites, the incorporation of automated analyzers and immunoassay technologies, the expanding application of cardiac marker testing within preventive cardiology practices, and a rising requirement for portable diagnostic instruments.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19358&type=smp
Which Drivers Are Advancing The Cardiac Marker Testing Market Growth?
The growing prevalence of cardiovascular diseases is projected to boost the expansion of the cardiac marker testing market moving forward. Cardiovascular diseases (CVDs) represent a category of conditions impacting the heart and blood vessels, encompassing ailments such as coronary artery disease, heart failure, and stroke. The increasing occurrences of cardiovascular diseases stem from factors like an unhealthy diet, physical inactivity, tobacco use, the harmful consumption of alcohol, and air pollution. Cardiac marker testing is crucial for cardiovascular diseases to precisely diagnose, assess the severity of, and monitor the progression or efficacy of treatment for heart conditions by detecting specific biomarkers released during myocardial injury. For instance, in January 2024, according to the American Heart Association, a US-based nonprofit organization, the age-adjusted death rate from cardiovascular disease escalated to 233.3 per 100,000, representing an increase of 4.0% from 224.4 per 100,000 when compared to 2023. Hence, the rising incidence of cardiovascular diseases propels the cardiac marker testing market.
How Is The Cardiac Marker Testing Market Structured Across Different Market Segments?
The cardiac marker testing market covered in this report is segmented –
1) By Product: Reagents And Kits, Instruments
2) By Biomarker Type: Troponin I And T, Creatine Kinase-MB (CK-MB), Natriuretic Peptide, Myoglobin, High-Sensitivity C-Reactive Protein, Other Biomarker Types
3) By Application: Laboratory Testing Facilities, Point-Of-Care Testing Facilities, Academic Institutions
Subsegments:
1) By Reagents and Kits: Troponin Test Kits, B-type Natriuretic Peptide (BNP) Test Kits, Creatine Kinase-MB (CK-MB) Test Kits, Myoglobin Test Kits, Other Cardiac Biomarker Reagents
2) By Instruments: Point-Of-Care Testing Devices, Automated Analyzers, Immunoassay Systems, Portable Diagnostic Devices
What Trends Are Influencing The Future Of The Cardiac Marker Testing Market?
Leading companies in the cardiac marker testing market are actively developing technologically advanced products, such as cardiac assays, to furnish valuable and precise data concerning heart health and function. Cardiac assays are diagnostic examinations designed to measure biomarkers or other indicators present in blood or various samples, used to assess heart function, diagnose cardiovascular diseases, or evaluate the risk of heart-related conditions. For example, in October 2023, Mindray, a medical device company from China, introduced its troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The hs-cTnI assay exhibits exceptional sensitivity, precision, and reliability, exceeding minimum standards by achieving a 93% detection rate between the limit of detection (LoD) and the 99th percentile upper reference limit (URL), and maintaining an imprecision coefficient of variation (CV) below 5% at the 99th URL, making it highly effective for identifying myocardial injury. Mindray’s NT-proBNP assay is a crucial cardiac marker for heart failure, displaying high precision with a coefficient of variation (CV) of =5%. It also efficiently reduces interference from 55 prevalent heart disease medications, guaranteeing accurate detection and management of heart failure.
Which Key Players Are Active In The Cardiac Marker Testing Market?
Major companies operating in the cardiac marker testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Tosoh Corporation, Guangzhou Wondfo Biotech Co. Ltd., Randox Laboratories Ltd., Getein Biotech Inc., Fujirebio Inc., Mayo Clinic Laboratories, Alere Inc., Nano-Ditech Corporation, Ortho Clinical Diagnostics, QuidelOrtho Corporation, DiaSorin S.p.A., PerkinElmer Inc., Meso Scale Diagnostics LLC, Boditech Med Inc., Response Biomedical Corp.
Access The Complete Cardiac Marker Testing Market Report:
https://www.thebusinessresearchcompany.com/report/cardiac-marker-testing-global-market-report
Which Region Stands As The Largest Contributor To The Cardiac Marker Testing Market?
North America was the largest region in the cardiac marker testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac marker testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Cardiac Marker Testing Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=19358&type=smp
Browse Through More Reports Similar to the Global Cardiac Marker Testing Market 2026, By The Business Research Company
Ventricular Assist Device Market Report 2026
https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report
Left Ventricular Assist Devices Market Report 2026
Interventional Cardiology Devices And Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model